. The company’s pipeline consists of four medical-stage therapies. Its most advanced drug applicant is ROS1 inhibitor taletrectinib for managing lung most cancers. Nuvation is finishing two stage 2 pivotal reports on taletrectinib. If penny stocks seem as well risky, there are alternate options. Look at investing in small-cap https://financefeeds.com/best-meme-coins-to-buy-for-50x-gains-as-the-market-recovers/